Crescent Biopharma Inc. (CBIO) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Crescent Biopharma Inc.

    NASDAQ: CBIO · Real-Time Price · USD
    11.72
    -0.31 (-2.58%)
    At close: Oct 03, 2025, 3:59 PM
    11.72
    0.00%
    After-hours: Oct 03, 2025, 05:45 PM EDT

    Crescent Biopharma Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -37.88M -36.9M -46.69M -63.43M
    Depreciation & Amortization
    		 35.17K 153.3K 207.15K 264.6K
    Stock-Based Compensation
    		 4.77M 3.56M 3.86M 6.09M
    Other Working Capital
    		 1.7M -2.46M -3.52M -1.18M
    Other Non-Cash Items
    		 814.48K 864.87K 828.51K 749.04K
    Deferred Income Tax
    		 n/a n/a n/a 2.17K
    Change in Working Capital
    		 1.16M -2.56M -4.66M -1.17M
    Operating Cash Flow
    		 -31.1M -34.88M -46.46M -57.49M
    Capital Expenditures
    		 -9.97K -21.39K -84.19K -14.94K
    Cash Acquisitions
    		 30K n/a n/a n/a
    Purchase of Investments
    		 n/a n/a n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a n/a n/a
    Other Investing Acitivies
    		 n/a n/a n/a n/a
    Investing Cash Flow
    		 20.03K -21.39K -84.19K -14.94K
    Debt Repayment
    		 n/a n/a n/a n/a
    Common Stock Repurchased
    		 n/a n/a n/a n/a
    Dividend Paid
    		 n/a n/a n/a n/a
    Other Financial Acitivies
    		 n/a 116.5K n/a 25.03K
    Financial Cash Flow
    		 5.4K 28.82M 4.16M 10.72M
    Net Cash Flow
    		 -31.07M -6.08M -42.38M -46.78M
    Free Cash Flow
    		 -31.11M -34.9M -46.54M -57.5M

    Add to Watchlist